Skip to main content
. 2024 Mar 14;98(5):1383–1398. doi: 10.1007/s00204-024-03704-7

Table 2.

Urinary elimination kineticsa of quantitatively and semi-quantitatively investigated metabolites and parent HMS in four volunteers after dermal sunscreen application (10% HMS, cis:trans 87.4:12.6)

cmax [µg L−1] cmax [µg (g creatinine)−1] tmax [h] t1/2
tHMS 102 (75–121) 62 (36–96) 6–15 29 (24–35)
cHMS 420 (320–538) 261 (158–361) 6–24 27 (22–32)
tHMS-CA (HMS-CA 1) 22 (20–23) 14 (9.6–24) 22–24 24 (21–29)
cHMS-CA (HMS-CA 4) 2.4 (2.0–2.9) 1.5 (0.93–2.9) 22–24 21 (18–28)
HMS-CA 5 2.8 (2.1–4.0)c 1.9 (1.0–4.4)c 24–27 24 (22–29)
3OH-tHMS (OH-HMS B) 3.5 (3.0–4.0) 2.2 (1.6–3.3) 15–24 26 (17–36)
3OH-cHMS (OH-HMS H) 2.6 (2.1–3.5) 1.6 (1.0–2.4) 6–24 28 (19–35)
HMS-CA 2b 0.069 (0.027–0.12) 0.048 (0.017–0.11) 22–35 n. a.d
HMS-CA 3b 0.12 (0.12–0.14) 0.082 (0.053–0.14) 24–25 n. a.d
OH-HMS A 58 (41–90) 35 (25–45) 15–24 23 (15–30)
OH-HMS C 22 (18–33) 14 (8.9–21) 15–24 23 (17–28)
OH-HMS D 5.8 (4.5–6.6) 3.5 (2.2–5.9) 6–24 24 (18–33)
OH-HMS E (E1 + E2) 52 (38–61) 33 (18–63) 6–24 25 (18–33)
OH-HMS F 2.1 (2.0–2.4) 1.3 (0.95–2.0) 15–24 27 (19–41)
OH-HMS G 19 (15–21) 11 (7.1–18) 6–24 27 (20–41)
OH-HMS I 4.2 (3.5–5.6) 2.8 (1.8–4.2) 18–24 33 (18–43)
OH-HMS K 5.0 (3.8–5.9) 3.0 (2.3–4.4) 14–20 31 (18–46)

Data are shown as mean values with ranges in parentheses, except for tmax, for which only ranges are shown. Semi-quantitatively analyzed metabolites in italics

acmax: unadjusted and creatinine-adjusted peak concentrations, tmax: time of creatinine-adjusted peak concentration, t1/2: terminal half-time, determined from excretion rate–time curves ≥ 36 h post-dose

bdata for HMS-CA isomers 2 and 3 are less reliable due to overlap with tHMS-CA tailing, low concentrations, and a minor matrix peak co-eluting with HMS-CA 3

csemi-quantitatively investigated using cHMS-CA calibration function

dcould not be determined due to too few samples above the LOQ